ArticleFrontiers in pharmacology2026

Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach.

Atena Zahedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.